Single and multiple inhibitors of the biosynthesis of 5‐, 12‐, 15‐lipoxygenase products derived from cinnamyl‐3,4‐dihydroxy‐α‐cyanocinnamate: Synthesis and structure–activity relationship

Documenti analoghi

• Development of 3β,4α‐dihydroxy‐5α‐androstan‐17‐one standard solution for doping analyses
  di: Miho Kuroe, et al.
  Pubblicazione: (2024)
• Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α‐glucosidase, α‐amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation
  di: Ahmed Ragab, et al.
  Pubblicazione: (2024)
• Design and synthesis of novel tetrabromophthalimide derivatives as potential tubulin inhibitors endowed with apoptotic induction for cancer treatment
  di: Marwa Abdel‐Motaal, et al.
  Pubblicazione: (2024)
• Design, synthesis, in silico, and in vitro evaluation of novel benzyloxybenzene substituted (S)‐α‐amino amide derivatives as cholinesterases and monoaminoxidases inhibitor
  di: Akın Akıncıoğlu
  Pubblicazione: (2024)
• 2‐Thioxo‐3,4‐dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFRT790M and VEGFR‐2 inhibitors: Design, synthesis, docking, and anticancer evaluations
  di: Mohamed S. A. El‐Gaby, et al.
  Pubblicazione: (2024)